LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply
AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.
—
Filed today
—
Companies tracked
NSE & BSE
Listed on
👋Welcome back, there — you're tracking 0 companies
🔔Sign in free to track companies and get alerts the moment they file
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors
Latest Filings —
📋 Filing Types Available on ForgeUp Filings
Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
The company appointed two board members linked to Carlyle investment group and reduced its employee stock option grant pool by 3,77,000 shares.
🤖 AI Summary
Board appointed Amit Jain (DIN: 06917608) as non-exec, non-independent director effective April 22, 2026
Board appointed Abhiroop Jayanthi (DIN: 10354445) as non-exec, non-independent director effective April 22, 2026
Both appointees represent Carlyle group; appointments subject to shareholder approval
ESOP 2026 pool revised down to 1,30,98,000 options from 1,34,75,000 options
🔢 Key Numbers — exact figures from BSE filing, not rounded
ESOP 2026 pool revised to
1,30,98,000 stock options
Original ESOP 2026 pool
1,34,75,000 stock options
ESOP pool reduction
3,77,000 stock options
🏢 How This Affects the Company
📈
Business Impact
Carlyle group representation on board signals ongoing strategic alignment with major investor. Board composition shifts governance control toward institutional capital, affecting strategic decision-making on acquisitions, divestitures, and capital allocation.
💰
Financial Impact
ESOP pool reduction of 3,77,000 options lowers potential share dilution. Lower grant capacity reduces future equity compensation expense and preserves per-share value for existing shareholders.
⚙️
Operational Impact
Addition of two institutional directors strengthens board-level oversight and governance maturity. Non-independent status indicates Carlyle retains operational influence over key decisions.
⚠️
Risk Impact
Carlyle's board presence may accelerate strategic changes or restructuring. Non-independent director classification raises governance risk if decisions prioritize investor exit over minority shareholder interests.
👥 What This Means For Shareholders
✅
Action Required
Attend forthcoming extraordinary general meeting to vote on appointment of Amit Jain and Abhiroop Jayanthi as directors.
👤
Who Is Affected
All shareholders. Carlyle-aligned board will influence strategic decisions on M&A, capital returns, and dividend policy. ESOP reduction lowers future per-share dilution for equity holders.
🔍
Management Signal
Management signals acceptance of institutional investor governance oversight and prioritizes lower equity dilution over aggressive employee stock compensation grants.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Shareholder approval meeting for director appointments — confirm ratification of Jain and Jayanthi
Board composition disclosures — verify final board size and committee assignments after shareholder approval
Next quarterly results — assess if Carlyle representation drives M&A or capital allocation changes
MEDIUM RISKNon-independent director majority with single investor concentration raises governance risk. Board instability from recent resignations compounds transition risk.
💡 Investor Takeaway
Board appointed two Carlyle-linked directors and reduced ESOP pool to 1,30,98,000 options. Both moves require shareholder approval. Reflects institutional investor influence over governance and capital management.
⚖️ Strengths & Concerns
✅ Positives
ESOP pool reduced by 3,77,000 options, lowering future equity dilution and preserving per-share value
Carlyle board presence strengthens institutional governance oversight and decision-making rigor
⚠️ Concerns
Both appointees non-independent and represent single investor, concentrating board influence toward Carlyle group
Appointment follows recent director resignations, indicating board instability and potential governance transition pressure
📅 Company Track Record
Company formerly known as Sequent Scientific Limited. Two non-executive directors resigned March 30, 2026, reducing board capacity. Current appointment replenishes board strength but concentrated in Carlyle representation.
Based on publicly available historical data. For context only.
All BSE filings we have analysed for Viyash Scientific Ltd.
You've read one filing
There are 32,000 more, and one of them is about a company you own
Follow a company and we'll email you the moment it files
again — explained, not just forwarded. Free.
Follow companies and get filings by email
Save any filing to read later
Two full AI analyses every month, free
No card needed. Sign in with Google in two taps.
⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔖
Save filings you care about
Sign in free to save any filing and get notified when the same company files again.
🔖
Save This Filing
Sign in with Google to save this filing and get notified when this company files again. Free, takes 5 seconds.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.